United Therapeutics Chairperson, CEO Rothblatt sells 9,500 shares for $4.92 million
UTHR•Rothblatt exercises options and related trusts sell shares
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 135.42 on Aug. 25.
- Family trusts sold 9,500 shares in multiple trades at weighted average prices near USD 516–520 on the same day.
- Holdings in the reported trust ended at 324,443 shares following the transactions.
